Cargando…

Discovery of 2-aminoquinolone acid derivatives as potent inhibitors of SARS-CoV-2

The COVID-19 pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to threaten human health and create socioeconomic problems worldwide. A library of 200,000 small molecules from the Korea Chemical Bank (KCB) were evaluated for their inhibitory activities agai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Young Sup, Lee, Jun Young, Jeon, Sangeun, Myung, Subeen, Gong, Hyun June, Kim, Seungtaek, Kim, Hyoung Rae, Jeong, Lak Shin, Park, Chul Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979702/ https://www.ncbi.nlm.nih.gov/pubmed/36870624 http://dx.doi.org/10.1016/j.bmcl.2023.129214

Ejemplares similares

Optimization of 2-Aminoquinazolin-4-(3H)-one Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties
por: Shin, Young Sup, et al.
Publicado: (2022)

Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2
por: Shin, Young Sup, et al.
Publicado: (2021)

Aminoquinolones and Their Benzoquinone Dimer Hybrids as Modulators of Prion Protein Conversion
por: Costa, Amanda Rodrigues Pinto, et al.
Publicado: (2022)

Design, synthesis and biological evaluation of 2-aminoquinazolin-4(3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments
por: Lee, Jun Young, et al.
Publicado: (2021)

Synthesis and biological evaluation of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4(1H)-one derivatives as potential MERS-CoV inhibitors
por: Yoon, Ji Hye, et al.
Publicado: (2019)

Identification of 6′-β-fluoro-homoaristeromycin as a potent inhibitor of chikungunya virus replication
por: Shin, Young Sup, et al.
Publicado: (2020)

Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of Dryopteris crassirhizoma by Targeting the Main Protease of SARS-CoV-2
por: Jin, Young-Hee, et al.
Publicado: (2022)

Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors
por: Lee, Jun Young, et al.
Publicado: (2020)

Broad Spectrum Antiviral Properties of Cardiotonic Steroids Used as Potential Therapeutics for Emerging Coronavirus Infections
por: Jin, Young-Hee, et al.
Publicado: (2021)

Natural Polyphenols, 1,2,3,4,6-O-Pentagalloyglucose and Proanthocyanidins, as Broad-Spectrum Anticoronaviral Inhibitors Targeting Mpro and RdRp of SARS-CoV-2
por: Jin, Young-Hee, et al.
Publicado: (2022)

Discovery of Oxazol-2-amine Derivatives as Potent Novel FLT3 Inhibitors
por: Kim, Hyo Jeong, et al.
Publicado: (2020)

Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections
por: Jin, Young-Hee, et al.
Publicado: (2021)

Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells
por: Kim, Dong Eon, et al.
Publicado: (2019)

Synthesis and structure–activity relationship study of saponin-based membrane fusion inhibitors against SARS-CoV-2
por: Jang, Youngho, et al.
Publicado: (2022)

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
por: Jeon, Sangeun, et al.
Publicado: (2020)

Lancemaside A from Codonopsis lanceolata: Studies on Antiviral Activity and Mechanism of Action against SARS-CoV-2 and Its Variants of Concern
por: Kim, Tai Young, et al.
Publicado: (2022)

Identification of 3-Oxindole Derivatives as Small Molecule HIV-1 Inhibitors Targeting Tat-Mediated Viral Transcription
por: Kim, Dong-Eun, et al.
Publicado: (2022)

An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus
por: Kim, Ki Hyun, et al.
Publicado: (2019)

6′-β-Fluoro-Homoaristeromycin and 6′-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1
por: Kovacikova, Kristina, et al.
Publicado: (2020)

Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation
por: Kim, Tai Young, et al.
Publicado: (2022)

Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How?
por: Park, Jin Sup, et al.
Publicado: (2022)

Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay
por: Jang, Woo Dae, et al.
Publicado: (2021)

Pretreatment of Anthocyanin from the Fruit of Vitis coignetiae Pulliat Acts as a Potent Inhibitor of TNF-α Effect by Inhibiting NF-κB-Regulated Genes in Human Breast Cancer Cells
por: Paramanantham, Anjugam, et al.
Publicado: (2020)

Discovery of 5-Phenoxy-2-aminopyridine Derivatives as Potent and Selective Irreversible Inhibitors of Bruton’s Tyrosine Kinase
por: Lee, Eun, et al.
Publicado: (2020)

Discovery of Potent and Specific Dihydroisoxazole Inhibitors of Human Transglutaminase 2
por: Klöck, Cornelius, et al.
Publicado: (2014)

Comprehensive Comparative Analysis of Local False Discovery Rate Control Methods
por: Kim, Shin June, et al.
Publicado: (2021)

Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug
por: Lee, BoRa, et al.
Publicado: (2022)

Design, synthesis, and biological evaluation of novel iso-d-2′,3′-dideoxy-3′-fluorothianucleoside derivatives
por: Kim, Kyung Ran, et al.
Publicado: (2007)

Development of an Advanced Synthetic Route to Macrosphelides and Its Application to the Discovery of a More Potent Macrosphelide Derivative
por: Heo, Yu Mi, et al.
Publicado: (2014)

Rapid discovery and classification of inhibitors of coronavirus infection by pseudovirus screen and amplified luminescence proximity homogeneous assay
por: Jeong, Kwiwan, et al.
Publicado: (2023)

Discovery of a novel potent peptide agonist to adiponectin receptor 1
por: Kim, Sunghwan, et al.
Publicado: (2018)

Evidence-based approaches for establishing the 2015 Dietary Reference Intakes for Koreans
por: Shin, Sangah, et al.
Publicado: (2018)

Investigation of phenyllactic acid as a potent tyrosinase inhibitor produced by probiotics
por: Shin, Minhye, et al.
Publicado: (2022)

Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug
por: Gan, Hanjie Jonathan, et al.
Publicado: (2021)

The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response (MAKE BETTER) Study: Design and Methodology
por: Kang, Hee-Ju, et al.
Publicado: (2018)

The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response (MAKE BETTER) Study: Design and Methodology
por: Kang, Hee-Ju, et al.
Publicado: (2019)

Chemical screen uncovers novel structural classes of inhibitors of the papain-like protease of coronaviruses
por: Jeong, Kwiwan, et al.
Publicado: (2022)

Early-Age Strength of Ultra-High Performance Concrete in Various Curing Conditions
por: Park, Jong-Sup, et al.
Publicado: (2015)

Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion
por: Kim, Tai Young, et al.
Publicado: (2021)

Potent P2Y(12) Receptor Inhibition in Korean Patients with Acute Myocardial Infarction
por: Kim, Yongcheol, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n5ot9gqqipbcal1cr5uluiqpdu